DND1: A Potential Drug Target and Biomarker for Dead End Proteins

Target Name: DND1

NCBI ID: G373863

DND1

DND1: A Potential Drug Target and Biomarker for Dead End Proteins

Introduction

Dead end proteins (DEPs) are a class of non-coding RNAs that play a crucial role in regulating gene expression and have been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. DEPs have a complex structure and function, with many unique features that make them attractive targets for drug development. One such protein is Dead end protein homolog 1 (DND1), which has been identified as a potential drug target and biomarker for various diseases.

Structure and Function of DND1

DND1 is a 21-kDa protein that is expressed in various tissues and cells in the human body. It has a unique open-loop structure and consists of a 100% conserved N-terminus, a characteristic alpha-helix, and a 尾-sheet region. The 尾-sheet region is the site of protein-protein interactions (PPIs) and is known for its role in protein-DNA interactions, which can modulate gene expression.

DND1 has been shown to play a role in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. It has been shown to interact with various protein partners, including DNA-binding proteins, histone modifiers, and transcription factors.

Potential Drug Targets

DND1 is a unique protein that has been identified as a potential drug target for various diseases. Its unique structure and function make it an attractive target for small molecules, antibodies, and other therapeutic agents. Here are some of the potential drug targets for DND1:

1.Cancer

DND1 has been shown to be involved in various cellular processes that are associated with cancer development. It has been shown to promote the growth and survival of cancer cells, and it has been shown to play a role in the development of neuroblastoma, a type of cancer that affects children.

2. Neurodegenerative Diseases

DND1 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. It has been shown to interact with various neurotransmitter receptors and to modulate the expression of genes involved in neurodegeneration.

3. Developmental Disorders

DND1 has been shown to be involved in the development and progression of developmental disorders, including Down syndrome, which is a genetic disorder that affects cognitive and physical development. It has been shown to interact with various genes involved in the development of Down syndrome and to play a role in the development of the disorder.

4.Inflammatory Diseases

DND1 has been shown to be involved in the development and progression of inflammatory diseases, including rheumatoid arthritis and multiple sclerosis. It has been shown to interact with various cytokines and to modulate the expression of genes involved in inflammation.

Biomarker Potential

DND1 has also been shown to be a potential biomarker for various diseases. Its unique structure and function make it an attractive target for diagnostic tools, such as antibodies or DNA-based assays. Here are some of the potential biomarkers for DND1:

1.Cancer

DND1 has been shown to be involved in the development and progression of cancer, and it has been used as a potential biomarker for cancer. For example, researchers have used DND1 antibodies to detect cancer cells in various tissues and have shown that the antibodies can effectively discriminate between cancer cells and normal cells.

2. Neurodegenerative Diseases

DND1 has been shown to be involved in the development and progression of neurodegenerative diseases, and it has been used as a potential biomarker for these conditions. For example, researchers have used DND1 antibodies to detect neurodegenerate changes in brain tissue and have shown that the antibodies can effectively detect the presence of neurodegenerate changes.

3. Developmental Disorders

DND1 has been shown to be involved in

Protein Name: DND MicroRNA-mediated Repression Inhibitor 1

Functions: RNA-binding factor that positively regulates gene expression by prohibiting miRNA-mediated gene suppression. Relieves miRNA repression in germline cells (By similarity). Prohibits the function of several miRNAs by blocking the accessibility of target mRNAs. Sequence-specific RNA-binding factor that binds specifically to U-rich regions (URRs) in the 3' untranslated region (3'-UTR) of several mRNAs. Does not bind to miRNAs. May play a role during primordial germ cell (PGC) survival (By similarity). However, does not seem to be essential for PGC migration (By similarity)

The "DND1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DND1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets